The Department of Drug Administration said that the batch of products of DSK UV Sunscreen Milk - box 1 tube 35g due to not meeting quality standards on microorganistic limitations.
The batch of products that was suspended had the receipt number of the declaration form: 16682/23/CBMP-HN; batch number: 2308008; date of manufacture: August 19, 2023; expiration date: August 18, 2026. The label states that the organization responsible for bringing the product to the market is VSHINE Pharmaceutical Joint Stock Company (business address: No. 24, Lane 118 Nguyen Khanh Toan, Hanoi); manufactured by Kosna Vietnam Pharmaceutical and Cosmetic Joint Stock Company (address: craft village industrial cluster, Duong Lieu commune, Hanoi).
The cosmetic sample discovered to be of poor quality was taken at Anh Thu Pharmacy (52 Pham Van Nghi, Ninh Binh province) and tested by the Pharmaceutical and Cosmetic Testing Center - Ninh Binh Department of Health. Test results showed that the sample did not meet the requirements for microorganism limitations.
The Drug Administration of Vietnam requires the Department of Health of provinces and centrally run cities to notify cosmetic businesses and users in the area to immediately stop trading and using the above product batch and proceeding to recall and destroy it according to regulations; supervise the implementation process and strictly handle violations.
VSHINE Pharmaceutical Joint Stock Company and Kosna Vietnam Pharmaceutical and Cosmetic Joint Stock Company must send a recall notice to the distribution locations, receive the product and destroy the entire batch of violating products. At the same time, report the results of recovery and destruction to the Department of Drug Administration before August 11, 2025.
The Hanoi Department of Health is responsible for supervising the two companies in recovering and destroying products; checking compliance with legal regulations in cosmetic production and trading activities and handling violations, especially the incorrect recording of addresses on product labels compared to the published records. The test results must be sent to the Department of Drug Administration before August 26, 2025.
